News
Regeneron’s REGN-COV2 antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients
Regeneron Pharmaceuticals, Inc. announced the first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 showing it reduced viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19....
News
BryoLogyx Announces Completion of World’s First GMP Synthesis of Bryostatin-1
BryoLogyx, Inc., announced that it has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good Manufacturing Practice (GMP) regulations. Bryostatin-1 is the company’s lead compound being developed to improve patient outcomes by amplifying the response and increasing the...
Clinical Trials
Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials
At Johnson & Johnson, there is no greater priority than the safety and well being of the people we serve every day around the world. We are committed to providing transparent updates throughout the clinical development process of our...
News
New Zealand signs deal with Pfizer, BioNTech for Covid-19 vaccine
The New Zealand government signed a deal on Monday to buy 1.5 million COVID-19 vaccines from Pfizer Inc and Germany’s BioNTech, with delivery potentially as early as the first quarter of 2021.
The government did not disclose financial terms of...
News
Pistoia Alliance launches seed fund to drive biopharma and healthcare innovation
The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life science and healthcare R&D, launched its new Innovation Seed Fund to finance early stage concepts in biopharma and healthcare. It aims to fund...
News
High Purity New England Introduces Defined Tubing Routing for Single-Use Facilities
High Purity New England (HPNE), a leading supplier of biopharma equipment and process systems for the Biopharma industry announces its new line of Defined Tubing Routing (DTR), a flexible tubing support system targeted for single-use biopharmaceutical manufacturing. This modular...
News
China’s Experimental COVID-19 Vaccine Appears Safe In Early Trials Study
COVID-19 Vaccine: In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group's experimental shot showed no severe adverse reactions, its COVID-19 Vaccine: In a Phase 1 trial of 191 healthy participants...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
